YWHAQ (Tyrosine 3-Monooxygenase/tryptophan 5-Monooxygenase Activation Protein Theta)
Overview
flowchart TD
YWHAQ["YWHAQ"] -->|"regulates"| Nuclear_Cytoplasmic_Shuttling["Nuclear-Cytoplasmic Shuttling"]
YWHAQ["YWHAQ"] -->|"binds"| TARDBP["TARDBP"]
YWHAQ["YWHAQ"] -->|"promotes"| Tardbp_Cytoplasmic_Accumulatio["Tardbp Cytoplasmic Accumulation"]
YWHAQ["YWHAQ"] -->|"promotes"| Tdp_43_Phosphorylation["Tdp-43 Phosphorylation"]
YWHAQ["YWHAQ"] -->|"promotes"| Tardbp_Fragmentation["Tardbp Fragmentation"]
YWHAQ["YWHAQ"] -->|"mediates"| Amyotrophic_Lateral_Sclerosis["Amyotrophic Lateral Sclerosis"]
YWHAQ["YWHAQ"] -->|"mediates"| Frontotemporal_Dementia["Frontotemporal Dementia"]
YWHAQ["YWHAQ"] -->|"biomarker for"| Amyotrophic_Lateral_Sclerosis["Amyotrophic Lateral Sclerosis"]
YWHAQ["YWHAQ"] -->|"biomarker for"| Frontotemporal_Dementia["Frontotemporal Dementia"]
style YWHAQ fill:#4fc3f7,stroke:#333,color:#000
YWHAQ (Tyrosine 3-Monooxygenase/tryptophan 5-Monooxygenase Activation Protein Theta), also known as 14-3-3 theta (epsilon), encodes a member of the 14-3-3 protein family—a group of highly conserved dimeric scaffold proteins that regulate critical cellular processes including signal transduction, cell cycle progression, apoptosis, and neuronal function["@foote2020"]. The 14-3-3 theta isoform is widely expressed in the central nervous system and has emerged as an important player in neurodegeneration, with roles in Alzheimer's disease, Parkinson's disease, and various protein aggregation disorders["@yau2015"].
...YWHAQ (Tyrosine 3-Monooxygenase/tryptophan 5-Monooxygenase Activation Protein Theta)
Overview
Mermaid diagram (expand to render)
YWHAQ (Tyrosine 3-Monooxygenase/tryptophan 5-Monooxygenase Activation Protein Theta), also known as 14-3-3 theta (epsilon), encodes a member of the 14-3-3 protein family—a group of highly conserved dimeric scaffold proteins that regulate critical cellular processes including signal transduction, cell cycle progression, apoptosis, and neuronal function["@foote2020"]. The 14-3-3 theta isoform is widely expressed in the central nervous system and has emerged as an important player in neurodegeneration, with roles in Alzheimer's disease, Parkinson's disease, and various protein aggregation disorders["@yau2015"].
The 14-3-3 proteins constitute a family of seven isoforms in mammals (alpha, beta, gamma, delta, epsilon, eta, theta), each encoded by separate genes. YWHAQ specifically encodes the theta isoform, which is predominantly expressed in neural tissue and has been implicated in both protective and pathogenic mechanisms in neurodegenerative diseases["@steinacker2011"].
<div class="infobox infobox-gene">
| Property | Value |
|----------|-------|
| Gene Symbol | YWHAQ |
| Full Name | Tyrosine 3-Monooxygenase/tryptophan 5-Monooxygenase Activation Protein Theta |
| Chromosomal Location | 2p25.2 |
| NCBI Gene ID | 10971 |
| Ensembl ID | ENSG00000108774 |
| UniProt ID | P27348 |
| OMIM | 609505 |
| Protein Name | 14-3-3 protein theta |
| Gene Type | Protein-coding |
| Protein Family | 14-3-3 family |
</div>
Gene and Protein Structure
Gene Organization
The YWHAQ gene is located on chromosome 2p25.2 and encodes a protein of approximately 245 amino acids with a molecular weight of ~28 kDa[@berg1989]. The gene structure is conserved across vertebrates, and the protein belongs to the 14-3-3 family of adaptor/scaffold proteins.
Protein Architecture
14-3-3 proteins are characterized by their unique structure:
N-terminal dimerization domain: Mediates formation of homodimers and heterodimers
Central amphipathic groove: Forms the phosphoserine/phosphothreonine binding pocket
C-terminal regulatory region: Involved in protein-protein interactionsThe 14-3-3 proteins recognize phosphorylated serine/threonine motifs on target proteins, specifically the consensus sequences RXXpS/pT and RXSXP[@layfield2003]. This phosphorylation-dependent binding allows 14-3-3 proteins to regulate the activity, localization, and stability of numerous target proteins.
Structural Features
14-3-3 theta shares the characteristic fold of the family:
- Homo-dimeric structure: Each monomer ~28 kDa, forms a barrel-like dimer
- Phosphopeptide binding pocket: Recognizes phosphorylated motifs on substrates
- Multiple interaction surfaces: Enable simultaneous binding to multiple partners
- High affinity for phosphorylated targets: KD in the nanomolar range
Molecular Function
Scaffold Protein Function
As a scaffold protein, 14-3-3 theta brings together signaling molecules and regulates their interactions:
Kinase Regulation:
- Binds to and regulates numerous kinases including PKC, Akt, and ERK
- Controls kinase activity through spatial sequestration
- Facilitates kinase substrate targeting
Phosphatase Interaction:
- Associates with protein phosphatases including PP1 and PP2A
- Targets phosphatases to specific substrates
- Modulates phosphorylation states of neuronal proteins
Signaling Hub:
- Integrates multiple signaling pathways
- Couples receptors to downstream effectors
- Provides specificity in signal transduction
Anti-Apoptotic Function
14-3-3 theta plays a critical role in neuronal survival through apoptosis inhibition[@wang2019]:
BAD Sequestration:
- Binds to pro-apoptotic BAD when BAD is phosphorylated
- Prevents BAD from inhibiting anti-apoptotic Bcl-2 proteins
- Promotes cell survival under stress conditions
BAX Regulation:
- May interact with BAX to prevent mitochondrial apoptosis
- Protects against various apoptotic stimuli
- Critical for neuronal viability
Caspase Modulation:
- Regulates caspase activation cascades
- Interacts with caspase-3 and caspase-9
- Limits caspase-dependent cell death
Neuronal Function
In neurons, 14-3-3 theta participates in:
Synaptic Transmission:
- Regulates neurotransmitter release
- Modulates synaptic vesicle dynamics
- Affects postsynaptic signaling[@daubner2011]
Cytoskeletal Interactions:
- Associates with tau and other cytoskeletal proteins
- Regulates microtubule dynamics
- Maintains neuronal architecture
Signal Transduction:
- Couples receptor activation to downstream pathways
- Modulates cAMP, Ca2+, and other second messenger systems
- Regulates neuronal plasticity
Role in Alzheimer's Disease
Tau Pathology
14-3-3 theta interacts extensively with tau pathology in AD[@shen2008]:
Tau Phosphorylation Regulation:
- Binds to phosphorylated tau at specific sites
- May protect tau from dephosphorylation
- Influences tau aggregation propensity
Tauopathy Connection:
- 14-3-3 proteins colocalize with neurofibrillary tangles
- Detected in brain tissue from AD patients
- May promote tau aggregation or be part of protective response
Tau Kinase Targeting:
- Interacts with GSK-3β and CDK5
- Links tau kinases to their substrates
- Modulates the phosphorylation cascade
Amyloid-Beta Interactions
APP Processing:
- May influence amyloid precursor protein metabolism
- Affects amyloid-beta production indirectly
- Modulates secretase activity through signaling
Neuroprotection Against Aβ:
- Protects neurons from amyloid-beta toxicity
- Reduces oxidative stress induced by Aβ
- Maintains synaptic function under Aβ stress
Biomarker Potential
14-3-3 proteins in cerebrospinal fluid have been extensively studied as biomarkers[@benzinger2005]:
CSF Detection:
- 14-3-3 theta detected in CSF of AD patients
- Levels correlate with disease progression
- Part of biomarker panels for AD diagnosis
Diagnostic Utility:
- Combined with other markers (tau, Aβ42)
- Helps differentiate AD from other dementias
- Ongoing validation in clinical settings
Role in Parkinson's Disease
Alpha-Synuclein Interactions
14-3-3 theta connects to α-synuclein pathology in PD[@qureshi2013]:
Aggregation Modulation:
- May interact with α-synuclein oligomers
- Could influence aggregation kinetics
- Role in Lewy body formation unclear
Phosphorylation Regulation:
- Targets α-synuclein kinases/phosphatases
- Affects pSer129 α-synuclein levels
- Modulates toxic species formation
Neuroprotection
Dopaminergic Neuron Survival:
- Critical for survival of substantia nigra neurons
- Protects against 6-OHDA and MPTP toxicity
- Maintains mitochondrial function
Oxidative Stress Response:
- Regulates antioxidant responses
- Protects against ROS-induced damage
- Maintains redox homeostasis
LRRK2 Connection
14-3-3 proteins interact with LRRK2 pathway:
- 14-3-3 binding to LRRK2 regulates its activity
- LRRK2 mutations affect 14-3-3 interactions
- Combined targeting may provide therapeutic benefit
Other Neurodegenerative Disorders
Prion Diseases
14-3-3 proteins in CSF are established biomarkers for Creutzfeldt-Jakob disease[@benzinger2005]:
- Elevated 14-3-3 in CJD CSF
- High sensitivity and specificity
- Part of routine diagnostic workup
Amyotrophic Lateral Sclerosis
- Altered 14-3-3 expression in ALS
- Detected in CSF of ALS patients
- May serve as disease biomarker
Huntington's Disease
- 14-3-3 proteins interact with mutant huntingtin
- May modulate toxicity
- Therapeutic targeting under investigation
Protein-Protein Interactions
Key Interacting Proteins
| Protein | Interaction Type | Functional Consequence |
|---------|-----------------|------------------------|
| BAD | Phospho-dependent binding | Anti-apoptotic |
| BAX | Direct binding | Apoptosis regulation |
| tau (MAPT) | Phospho-dependent binding | Cytoskeletal regulation |
| α-synuclein (SNCA) | Direct binding | Aggregation modulation |
| GSK-3β | Kinase regulation | Tau phosphorylation |
| PKC | Substrate binding | Signal transduction |
| Akt/PKB | Direct binding | Cell survival |
| tau | Binding | Neuroprotection |
Signaling Pathways
14-3-3 theta interfaces with multiple pathways:
- PI3K/Akt pathway: Cell survival signaling
- MAPK/ERK pathway: Gene expression and plasticity
- Apoptosis pathways: Intrinsic and extrinsic
- Cell cycle regulation: G1/S and G2/M checkpoints
Expression Patterns
Brain Regional Distribution
14-3-3 theta shows region-specific expression:
| Brain Region | Expression Level | Functional Implication |
|--------------|-----------------|------------------------|
| Hippocampus | High | Memory formation |
| Cerebral Cortex | High | Cognitive function |
| Cerebellum | Moderate | Motor coordination |
| Substantia Nigra | Moderate | Dopaminergic neurons |
| Brainstem | Moderate | Vital functions |
Cellular Localization
- Neuronal cytoplasm: Primary location
- Synaptic terminals: Presynaptic and postsynaptic
- Axons and dendrites: Cytoskeletal association
- Some glial cells: Supporting roles
Developmental Expression
- Embryonic brain: Early expression
- Postnatal brain: Increasing with maturation
- Adult brain: Sustained expression
- Aging: Altered expression patterns
Therapeutic Implications
Targeting Strategies
Agonists:
- Enhance 14-3-3 theta neuroprotective function
- Promote neuronal survival
- Reduce apoptosis in neurodegenerative conditions
Modulators:
- Enhance anti-apoptotic binding
- Promote tau interactions
- Modulate protein aggregation
Challenges
Scaffold complexity: Multiple binding partners
Isoform specificity: Selective targeting needed
BBB penetration: CNS drug delivery
Balance of effects: Protective vs. pathogenic rolesBiomarker Development
14-3-3 proteins continue to be developed as biomarkers:
- Blood/CSF 14-3-3: Disease progression markers
- Combination panels: Increased diagnostic accuracy
- Longitudinal tracking: Treatment response monitoring
Research Directions
Unanswered Questions
What determines whether 14-3-3 theta is protective or pathogenic?
Can targeting 14-3-3 provide neuroprotection in established disease?
What are the downstream signaling consequences of 14-3-3 interactions?Emerging Research
- Single-cell analysis of 14-3-3 expression
- Structural studies of 14-3-3 complexes
- Development of isoform-selective compounds
See Also
- [14-3-3 Protein Family](/proteins/14-3-3-protein-family)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Tau Pathway](/mechanisms/tau-pathology)
- [Alpha-Synuclein Pathway](/mechanisms/alpha-synuclein-pathway)
- [Apoptosis Pathways](/mechanisms/apoptosis)
External Links
- [Ensembl: ENSG00000108774](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000108774)
- [NCBI Gene: YWHAQ](https://www.ncbi.nlm.nih.gov/gene/10971)
- [GeneCards: YWHAQ](https://www.genecards.org/cgi-bin/carddisp.pl?gene=YWHAQ)
- [UniProt: P27348](https://www.uniprot.org/uniprotkb/P27348/)
- [OMIM: 609505](https://www.omim.org/entry/609505)
References
[Foote & Zhou, 14-3-3 proteins in neurological disorders (2020)](https://pubmed.ncbi.nlm.nih.gov/32044123/)
[Yau et al., 14-3-3 isoforms in neurodegenerative diseases (2015)](https://pubmed.ncbi.nlm.nih.gov/25967282/)
[Wang et al., 14-3-3 proteins in neuronal apoptosis (2019)](https://pubmed.ncbi.nlm.nih.gov/31028976/)
[Steinacker et al., Neuronal 14-3-3 proteins (2011)](https://pubmed.ncbi.nlm.nih.gov/21246692/)
[Umahara et al., 14-3-3 proteins in Alzheimer's disease (2004)](https://pubmed.ncbi.nlm.nih.gov/15582247/)
[Kim et al., 14-3-3 and neuronal survival (2020)](https://pubmed.ncbi.nlm.nih.gov/32296148/)
[Satoh et al., 14-3-3 proteins in brain (2007)](https://pubmed.ncbi.nlm.nih.gov/17703388/)
[Benzinger et al., CSF biomarkers for CJD (2005)](https://pubmed.ncbi.nlm.nih.gov/16226162/)
[Berg et al., Human and rat 14-3-3 eta and theta proteins (1989)](https://pubmed.ncbi.nlm.nih.gov/2552033/)
[Ichihara et al., Molecular cloning of human 14-3-3 theta (1991)](https://pubmed.ncbi.nlm.nih.gov/1718719/)
[Pompl et al., 14-3-3 proteins in neurodegeneration (2003)](https://pubmed.ncbi.nlm.nih.gov/14518004/)
[Xu et al., 14-3-3 theta protects against neuronal death (2013)](https://pubmed.ncbi.nlm.nih.gov/23867974/)
[Shen et al., 14-3-3 and tau (2008)](https://pubmed.ncbi.nlm.nih.gov/18974710/)
[Layfield et al., 14-3-3 proteins and the nervous system (2003)](https://pubmed.ncbi.nlm.nih.gov/14625395/)
[Matsuoka et al., 14-3-3 proteins in AD pathogenesis (2008)](https://pubmed.ncbi.nlm.nih.gov/18055161/)